{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:44:02Z","timestamp":1790304242471,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573744"],"award-info":[{"award-number":["81573744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973841"],"award-info":[{"award-number":["81973841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Coronary slow flow (CSF) is characterized by delayed opacification of distal epicardial coronary arteries without significant coronary stenosis. In addition, The changes of lipoprotein-associated phospholipase A2 (Lp-PLA<jats:sub>2<\/jats:sub>) as a significant predictive factor for CSF remain controversial. The study aims to investigate the association between plasma Lp-PLA<jats:sub>2<\/jats:sub> and CSF.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective study, 170 consecutive patients who underwent coronary angiography were enrolled in Beijing Anzhen Hospital from January 2017 to September 2019, and were divided into CSF group and normal control groups. According to coronary blood flow rate measured by the thrombolysis in myocardial infarction frame count (TFC) method, CSF was defined as TFC\u2009&gt;\u200927. Serum Lp-PLA<jats:sub>2<\/jats:sub> levels were measured in an enzyme-linked immunosorbent assay.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Lp-PLA<jats:sub>2<\/jats:sub> levels were higher in the CSF group than in the control group (288.6\u2009\u00b1\u200950.3 versus 141.9\u2009\u00b1\u200949.7, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and were significantly correlated with the mean coronary artery thrombolysis in myocardial infarction (TIMI) frame count (r\u2009=\u20090.790, P&lt;0.001). Logistic regression analysis showed that high Lp-PLA<jats:sub>2<\/jats:sub> was independently associated with CSF after adjustment for conventional risk factors (OR\u2009=\u20091.040, CI\u2009=\u20091.022\u20131.059, P&lt;0.001). Male sex (OR\u2009=\u20092.192, CI\u2009=\u20091.161\u20134.140, <jats:italic>P<\/jats:italic>\u2009=\u20090.016) and hypertension (OR\u2009=\u20091.965, CI\u2009=\u20091.034\u20133.736, <jats:italic>P<\/jats:italic>\u2009=\u20090.039) were also CSF risk factors. Receiver-operating characteristic curve (ROC) analysis showed that Lp-PLA<jats:sub>2<\/jats:sub> levels can predict CSF severity; the predictive power was higher than the other risk factors.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our study demonstrated that patients with CSF had higher circulating levels of Lp-PLA<jats:sub>2<\/jats:sub> than normal controls. After adjustment for potential confounders, increased Lp-PLA<jats:sub>2<\/jats:sub> was independently associated with presence of CSF.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01463-8","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T09:02:48Z","timestamp":1590570168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow"],"prefix":"10.1186","volume":"20","author":[{"given":"Yao-dong","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-qiang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-long","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"issue":"3","key":"1463_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jelectrocard.2011.07.003","volume":"45","author":"B Horjeti","year":"2012","unstructured":"Horjeti B, Goda A. Acute ischemia manifestation in a patient with coronary slow flow phenomenon. J Electrocardiol. 2012;45(3):277\u20139.","journal-title":"J Electrocardiol"},{"issue":"1","key":"1463_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0002-8703(72)90307-9","volume":"84","author":"AA Tambe","year":"1972","unstructured":"Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries--a new angiographic finding. Am Heart J. 1972;84(1):66\u201371.","journal-title":"Am Heart J"},{"issue":"1","key":"1463_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cbf.3313","volume":"36","author":"Z Jin","year":"2018","unstructured":"Jin Z, Tan Q, Sun B. Telmisartan ameliorates vascular endothelial dysfunction in coronary slow flow phenomenon (CSFP). Cell Biochem Funct. 2018;36(1):18\u201326.","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"1463_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/0300060516664637","volume":"44","author":"M Yilmaz","year":"2016","unstructured":"Yilmaz M, Korkmaz H, Bilen MN, Uku O, Kurtoglu E. Could neutrophil\/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow? J Int Med Res. 2016;44(6):1443\u201353.","journal-title":"J Int Med Res"},{"issue":"4","key":"1463_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1253\/circj.CJ-11-0959","volume":"76","author":"BM Hawkins","year":"2012","unstructured":"Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow--prevalence and clinical correlations. Circ J. 2012;76(4):936\u201342.","journal-title":"Circ J"},{"issue":"5","key":"1463_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/bmm-2016-0022","volume":"10","author":"C Yayla","year":"2016","unstructured":"Yayla C, Akboga MK, Gayretli Yayla K, Ertem AG, Efe TH, Sen F, Unal S, Acar B, Ozcan F, Turak O, et al. A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio. Biomark Med. 2016;10(5):485\u201393.","journal-title":"Biomark Med"},{"issue":"1","key":"1463_CR7","first-page":"34","volume":"19","author":"FO Mutluer","year":"2018","unstructured":"Mutluer FO, Ural D, Gungor B, Bolca O, Aksu T. Association of Interleukin-1 gene cluster polymorphisms with coronary slow flow phenomenon. Anatolian J Cardiol. 2018;19(1):34\u201341.","journal-title":"Anatolian J Cardiol"},{"issue":"4","key":"1463_CR8","first-page":"4091","volume":"8","author":"GL Shi","year":"2015","unstructured":"Shi GL, Cai XX, Su YM, Chen C, Deng XT, Pan HY, Fan MK, Zhu JH, Pan M. Interleukin-10 promotor -592A\/C polymorphism is associated with slow coronary flow in Han Chinese. Int J Clin Exp Pathol. 2015;8(4):4091\u20138.","journal-title":"Int J Clin Exp Pathol"},{"key":"1463_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1476-511X-10-170","volume":"10","author":"IT Silva","year":"2011","unstructured":"Silva IT, Mello AP, Damasceno NR. Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase a(2) (Lp-PLA(2)): a review. Lipids Health Dis. 2011;10:170.","journal-title":"Lipids Health Dis"},{"key":"1463_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.enz.2015.09.004","volume":"38","author":"DM Stafforini","year":"2015","unstructured":"Stafforini DM. Plasma PAF-AH (PLA2G7): biochemical properties, association with LDLs and HDLs, and regulation of expression. Enzymes. 2015;38:71\u201393.","journal-title":"Enzymes"},{"key":"1463_CR11","doi-asserted-by":"publisher","first-page":"934681","DOI":"10.1155\/2015\/934681","volume":"2015","author":"M Acevedo","year":"2015","unstructured":"Acevedo M, Varleta P, Kramer V, Valentino G, Quiroga T, Prieto C, Parada J, Adasme M, Briones L, Navarrete C. Comparison of lipoprotein-associated phospholipase A2 and high sensitive C-reactive protein as determinants of metabolic syndrome in subjects without coronary heart disease: in search of the best predictor. Int J Endocrinol. 2015;2015:934681.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"1463_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","volume":"109","author":"CM Ballantyne","year":"2004","unstructured":"Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, Sharrett AR. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the atherosclerosis risk in communities (ARIC) study. Circulation. 2004;109(7):837\u201342.","journal-title":"Circulation"},{"issue":"3","key":"1463_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"5","key":"1463_CR14","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. Report of the 1995 World Health Organization\/international society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841\u20132.","journal-title":"Circulation"},{"issue":"7","key":"1463_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med. 1998;15(7):539\u201353.","journal-title":"Diab Med"},{"issue":"5","key":"1463_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint National Committee (JNC 8). Jama. 2014;311(5):507\u201320.","journal-title":"Jama"},{"issue":"5","key":"1463_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","volume":"93","author":"CM Gibson","year":"1996","unstructured":"Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879\u201388.","journal-title":"Circulation"},{"issue":"9\u201310","key":"1463_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5830\/CVJA-2013-072","volume":"24","author":"H Tasolar","year":"2013","unstructured":"Tasolar H, Eyyupkoca F, Akturk E, Karakus Y, Cansel M, Yagmur J, Ozyalin F, Altun B, Pekdemir H. Endothelial nitric oxide synthase levels and their response to exercise in patients with slow coronary flow. Cardiovasc J Afr. 2013;24(9\u201310):355\u20139.","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"1463_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0003319715574625","volume":"67","author":"MK Akboga","year":"2016","unstructured":"Akboga MK, Canpolat U, Balci KG, Akyel A, Sen F, Yayla C, Cay S, Aras D, Aydogdu S. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2016;67(1):21\u20136.","journal-title":"Angiology"},{"issue":"11","key":"1463_CR20","first-page":"1909","volume":"60","author":"B Demir","year":"2014","unstructured":"Demir B, Caglar IM, Tureli HO, Pirhan O, Aciksari G, Serkan C, Cem O, Gedikbasi A, Zorkun C, Demir E, et al. Coronary slow flow phenomenon associated with high serum levels of soluble CD40 ligand and urotensin II: a multi-marker approach. Clin Lab. 2014;60(11):1909\u201320.","journal-title":"Clin Lab"},{"issue":"1","key":"1463_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5603\/CJ.a2017.0132","volume":"25","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang H, Liang Y, Wang W, Xu T, Zhang J, Xiao W, Wang T. Effects of hyperbaric oxygen on vascular endothelial function in patients with slow coronary flow. Cardiol J. 2018;25(1):106\u201312.","journal-title":"Cardiol J"},{"issue":"1","key":"1463_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2003.06.025","volume":"97","author":"H Pekdemir","year":"2004","unstructured":"Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, Doven O, Katircibasi MT, Muslu N. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol. 2004;97(1):35\u201341.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1463_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2007.12.028","volume":"200","author":"A Camsari","year":"2008","unstructured":"Camsari A, Ozcan T, Ozer C, Akcay B. Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis. 2008;200(2):310\u20134.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1463_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2143\/AC.59.2.2005166","volume":"59","author":"H Pekdemir","year":"2004","unstructured":"Pekdemir H, Cin VG, Cicek D, Camsari A, Akkus N, Doven O, Parmaksiz HT. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol. 2004;59(2):127\u201333.","journal-title":"Acta Cardiol"},{"issue":"5","key":"1463_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5152\/akd.2014.5376","volume":"15","author":"M Oylumlu","year":"2015","unstructured":"Oylumlu M, Dogan A, Oylumlu M, Yildiz A, Yuksel M, Kayan F, Kilit C, Amasyali B. Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Anatolian J Cardiol. 2015;15(5):391\u20135.","journal-title":"Anatolian J Cardiol"},{"issue":"1\u20132","key":"1463_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2007.05.024","volume":"385","author":"JJ Li","year":"2007","unstructured":"Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, Zhang CY, Li J. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin chim Acta. 2007;385(1\u20132):43\u20137.","journal-title":"Clin chim Acta"},{"key":"1463_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","volume":"84","author":"N Di Pietro","year":"2016","unstructured":"Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vasc Pharmacol. 2016;84:1\u20137.","journal-title":"Vasc Pharmacol"},{"issue":"12a","key":"1463_CR28","doi-asserted-by":"publisher","first-page":"51f","DOI":"10.1016\/j.amjcard.2008.04.019","volume":"101","author":"MH Davidson","year":"2008","unstructured":"Davidson MH, Corson MA, Alberts MJ, Anderson JL, Gorelick PB, Jones PH, Lerman A, McConnell JP, Weintraub HS. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol. 2008;101(12a):51f\u20137f.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1463_CR29","doi-asserted-by":"publisher","first-page":"030701","DOI":"10.11613\/BM.2017.030701","volume":"27","author":"A De Stefano","year":"2017","unstructured":"De Stefano A, Mannucci L, Massoud R, Bernardini S, Cortese C. Performance characteristics of lipoprotein-associated phospholipase A2 activity assay on the dimension vista analyser and preliminary study of a healthy Italian population. Biochem Med. 2017;27(3):030701.","journal-title":"Biochem Med"},{"issue":"1","key":"1463_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/CH-2012-1538","volume":"52","author":"Y Arbel","year":"2012","unstructured":"Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I, Mashav N, Thurm T, Keren G, Finkelstein A. Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc. 2012;52(1):5\u201314.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"1463_CR31","doi-asserted-by":"publisher","first-page":"e30296","DOI":"10.5812\/cardiovascmed.30296","volume":"5","author":"H Sanati","year":"2016","unstructured":"Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr A, Peighambari M, Shokrian L, Ashrafi P. Coronary slow flow phenomenon clinical findings and predictors. Res Cardiovasc Med. 2016;5(1):e30296.","journal-title":"Res Cardiovasc Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01463-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01463-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01463-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:20:09Z","timestamp":1622071209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01463-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01463-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Beijing Anzhen Hospital Ethics Committee of Capital Medical University, and all participants signed an informed consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent before enrollment in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest<b>s.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}